| PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION |
19. PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION Condensed balance sheets
| | | As of | | | | | December 31, 2025 | | | June 30, 2026 | | | | | RMB | | | RMB | | | US$ | | | ASSETS | | | | | | | | | | | Current assets: | | | | | | | | | | | Cash and cash equivalents | | | 7,549 | | | | 6,474 | | | | 954 | | | Amount due from subsidiaries | | | 241,409 | | | | 234,233 | | | | 34,522 | | | Other current assets | | | 800 | | | | — | | | | — | | | Total current assets | | | 249,758 | | | | 240,707 | | | | 35,476 | | | | | | | | | | | | | | | | | Non-current assets | | | | | | | | | | | | | | Intangible assets | | | 10,947 | | | | 10,002 | | | | 1,474 | | | Investment in subsidiaries | | | (167,698 | ) | | | (163,992 | ) | | | (24,169 | ) | | Total non-current assets | | | (156,751 | ) | | | (153,990 | ) | | | (22,695 | ) | | Total assets | | | 93,007 | | | | 86,717 | | | | 12,781 | | | | | As of | | | | | December 31, 2025 | | | June 30, 2026 | | | | | RMB | | | RMB | | | US$ | | | LIABILITIES AND SHAREHOLDERS’ EQUITY | | | | | | | | | | | | | | | | | | | | | | Accounts payable | | | — | | | | — | | | | — | | | Amount due to subsidiaries | | | 9,142 | | | | 8,801 | | | | 1,297 | | | Total liabilities | | | 9,142 | | | | 8,801 | | | | 1,297 | | | | | | | | | | | | | | | | | Shareholders’ equity: | | | | | | | | | | | | | | Ordinary shares (US$0.00001428571428 par value; 3,500,000,000 and 3,500,000,000 shares authorized; 1,423,285,396 and 1,423,285,396 issued and outstanding as of December 31, 2025 and June 30, 2026, respectively) | | | 126 | | | | 126 | | | | 18 | | | Additional paid-in capital | | | 312,339 | | | | 319,058 | | | | 47,023 | | | Treasury stock | | | — | | | | (50 | ) | | | (6 | ) | | Statutory reserve | | | 7,596 | | | | 7,596 | | | | 1,120 | | | Accumulated deficit | | | (238,117 | ) | | | (247,847 | ) | | | (36,528 | ) | | Accumulated other comprehensive income | | | 1,921 | | | | (967 | ) | | | (143 | ) | | Total shareholders’ equity | | | 83,865 | | | | 77,916 | | | | 11,484 | | | Total liabilities, shareholders’ equity | | | 93,007 | | | | 86,717 | | | | 12,781 | | Condensed statement of comprehensive income | | | For the six months ended June 30, | | | | | 2025 | | | 2026 | | | | | RMB | | | RMB | | | US$ | | | Cost of revenues | | | — | | | | (187 | ) | | | (28 | ) | | Gross loss | | | — | | | | (187 | ) | | | (28 | ) | | Sales and marketing expenses | | | — | | | | — | | | | — | | | General and administrative expenses | | | (25 | ) | | | (8,186 | ) | | | (1,206 | ) | | Research and development expenses | | | (667 | ) | | | (419 | ) | | | (62 | ) | | Total operating expenses | | | (692 | ) | | | (8,605 | ) | | | (1,268 | ) | | Operating loss | | | (692 | ) | | | (8,792 | ) | | | (1,296 | ) | | Exchange gain (loss) | | | (1,606 | ) | | | 1,245 | | | | 183 | | | Share of loss from subsidiaries and Consolidated VIEs | | | (18,996 | ) | | | (2,183 | ) | | | (319 | ) | | Loss before taxes | | | (21,294 | ) | | | (9,730 | ) | | | (1,432 | ) | | Income tax expense | | | — | | | | — | | | | — | | | Net loss | | | (21,294 | ) | | | (9,730 | ) | | | (1,432 | ) | | | | | | | | | | | | | | | | Comprehensive loss | | | | | | | | | | | | | | Net loss | | | (21,294 | ) | | | (9,730 | ) | | | (1,432 | ) | | Other comprehensive loss | | | | | | | | | | | | | | Foreign currency translation adjustment | | | (1,085 | ) | | | (2,888 | ) | | | (426 | ) | | Total comprehensive loss | | | (22,379 | ) | | | (12,618 | ) | | | (1,858 | ) | Condensed statements of cash flows
| | | For the six months ended June 30, | | | | | 2025 | | | 2026 | | | | RMB | | | RMB | | | US$ | | | Net cash provided by (used in) operating activities | | | (2,784 | ) | | | 7,293 | | | | 1,075 | | | Net cash used in investing activities | | | (917 | ) | | | — | | | | — | | | Net cash provided by financing activities | | | 3,027 | | | | 50 | | | | 7 | | | Effect of exchange rate changes | | | — | | | | (8,418 | ) | | | (1,241 | ) | | Net decrease in cash and cash equivalents | | | (674 | ) | | | (1,075 | ) | | | (159 | ) | | Cash and cash equivalents at beginning of year | | | 10,995 | | | | 7,549 | | | | 1,113 | | | Cash and cash equivalents at end of year | | | 10,321 | | | | 6,474 | | | | 954 | | Basis of presentation In the Company-only financial statements, the Company’s investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries since inception. The Company records its investment in its subsidiary under the equity method of accounting as prescribed in ASC 323-10, Investment-Equity Method and Joint Ventures, and such investment is presented on the balance sheets as “Investments in subsidiaries” and the share of the subsidiaries’ profit or loss is presented as “Share of profits of subsidiaries and Consolidated VIEs” on the statements of operations. The subsidiaries did not pay any dividends to the Company for the years presented. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted and as such, these Company-only financial statements should be read in conjunction with the Company’s unaudited interim condensed consolidated financial statements.
|